Royalty Pharma to donate $7.5 million to expand therapy program
Royalty Pharma announced a $7.5 million donation to Blood Cancer United to support its Therapy Acceleration Program (TAP).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.